Belimumab With Rituximab for Primary Membranous Nephropathy
for
Membranous Nephropathy, Nephrotic Syndrome
Location: 20 recruiting locations
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT03949855
Phase2, Recruiting
Active & Responsive
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
for
Lupus Nephritis
Location: 1 recruiting location
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06527872
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
Location: 36 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
for
Lupus Nephritis
Location: 13 recruiting locations
Sponsor: HI-Bio, A Biogen Company
Sex: All
Age: 18 - 70+
Code: NCT06064929
Phase1, Phase2, Recruiting
Active & Responsive
Atacicept in Multiple Glomerular Diseases
for
pMN, IgAN, Nephrotic Syndrome, MCD, FSGS
Location: 1 recruiting location
Sponsor: Vera Therapeutics, Inc.
Sex: All
Age: 10+
Code: NCT06983028
Phase2, Recruiting
Active & Responsive
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: 6 recruiting locations
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase3, Recruiting
Active & Responsive
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)